These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34019585)

  • 21. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better association of waist circumference with insulin resistance and some cardiovascular risk factors than body mass index.
    Elbassuoni E
    Endocr Regul; 2013 Jan; 47(1):3-14. PubMed ID: 23363252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.
    Kruse R; Vienberg SG; Vind BF; Andersen B; Højlund K
    Diabetologia; 2017 Oct; 60(10):2042-2051. PubMed ID: 28721439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters.
    Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E
    BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
    Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary weight loss in insulin-resistant non-obese humans: Metabolic benefits and relationship to adipose cell size.
    McLaughlin T; Abbasi F; Lamendola C; Yee G; Carter S; Cushman SW
    Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):62-68. PubMed ID: 30497926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals.
    Slusher AL; Whitehurst M; Zoeller RF; Mock JT; Maharaj M; Huang CJ
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):839-845. PubMed ID: 26141939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy.
    Miehle K; Ebert T; Kralisch S; Hoffmann A; Kratzsch J; Schlögl H; Stumvoll M; Fasshauer M
    Cytokine; 2016 Jul; 83():239-244. PubMed ID: 27179139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons.
    Chavez AO; Gastaldelli A; Guardado-Mendoza R; Lopez-Alvarenga JC; Leland MM; Tejero ME; Sorice G; Casiraghi F; Davalli A; Bastarrachea RA; Comuzzie AG; DeFronzo RA; Folli F
    Cardiovasc Diabetol; 2009 Apr; 8():22. PubMed ID: 19389241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.
    Ko BJ; Kim SM; Park KH; Park HS; Mantzoros CS
    Int J Obes (Lond); 2014 Dec; 38(12):1497-502. PubMed ID: 24638201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of metabolically unhealthy overweight/obese African American women: significance of insulin-sensitive and insulin-resistant phenotypes.
    Gaillard TR; Schuster D; Osei K
    J Natl Med Assoc; 2012; 104(3-4):164-71. PubMed ID: 22774383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Overweight, obesity and underweight in HIV infected patients].
    Kwiatkowska W; Knysz B; Drelichowska-Durawa J; Czarnecki M; Gasiorowski J; Biłyk E; Karczewski M; Witkiewicz W
    Przegl Lek; 2013; 70(3):113-7. PubMed ID: 24003663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
    Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
    Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
    Wang D; Zhu W; Li J; An C; Wang Z
    PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of para- and perirenal fat and epicardial fat with metabolic parameters in overweight and obese subjects.
    Manno C; Campobasso N; Nardecchia A; Triggiani V; Zupo R; Gesualdo L; Silvestris F; De Pergola G
    Eat Weight Disord; 2019 Feb; 24(1):67-72. PubMed ID: 29956099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of an interdisciplinary weight loss program on fibroblast growth factor 21 and inflammatory biomarkers in women with overweight and obesity.
    Dâmaso AR; Machado PP; Rhein SO; Masquio DCL; Oyama LM; Boldarine VT; de Oliveira GI; Tock L; Thivel D; da Silveira Campos RM
    Arch Endocrinol Metab; 2021 Nov; 65(6):821-831. PubMed ID: 34762789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.